BIO-Europe Spring® 2017: Stirring the entrepreneurial pot in Europe

April 6, 2017

Europe is home to many of the biggest pharma companies and the best academic biomedical researchers. But the US is the dominant place with thriving hubs of biotech entrepreneurs, people taking big risk and creating much of the value in healthcare. Quite a few countries aspire to create their own dynamic clusters like Boston and San Francisco, but haven’t pulled it off. What is happening today in various European hotspots, at the intersection of academia and entrepreneurship?

Click here for more coverage of the activities held during BIO-Europe Spring

Previous Video
BIO-Europe Spring® 2017: Digimed and diagnostics: Market access and new collaborations
BIO-Europe Spring® 2017: Digimed and diagnostics: Market access and new collaborations

The effect of digital medicine on diagnostics is having and will continue to have a revolutionary effect on...

Next Video
BIO-Europe Spring® 2017: Commercializing cell and gene therapies
BIO-Europe Spring® 2017: Commercializing cell and gene therapies

New business models for clinical development and manufacturing require strategic partnerships among researc...